KBI Biopharma Inc., a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), has appointed Jean-Baptiste (JB) Agnus as its Chief Business Officer.
KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer
KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Peter Carbone as the new Chief Quality Officer, strengthening KBI’s expertise in Quality and Regulatory Affairs.
KBI Biopharma and Argonaut Manufacturing Services Forge Strategic Alliance
DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the recent appointment of Maggie Chen, Senior Vice President and Site Head of the Patriot Park mammalian cGMP manufacturing facility in Durham, North Carolina. She brings over 20 years of biopharmaceutical experience with a proven track record as a successful leader in Manufacturing, Manufacturing, Science & Technologies (MS&T), Quality, and Engineering. Chen now leverages her vast multi-disciplinary experience in leading the site’s day-to-day operations.
KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
KBI Biopharma, Inc. Continues to Strengthen Leadership and Expertise With Key Executive Appointments
KBI Biopharma, Inc., a JSR Life Sciences company, appointed Tony Fraij, chief operating officer; Shaguna Seth, chief of staff and global PMO leader; Katie Edgar, senior vice president of corporate strategy and alliance management; and Sarah Wakefield, senior vice president, corporate communications.
KBI's Aaron Pilling Discusses the KBI PUREplatform Launch at BIO International 2023